CSIMarket Company Name, Ticker, Competitors, else..
 
Bioaffinity Technologies Inc   (NASDAQ: BIAF)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 
Price: $0.2880 $0.00 -0.069%
Day's High: $0.2972 Week Perf: 0.52 %
Day's Low: $ 0.27 30 Day Perf: -63.08 %
Volume (M): 148 52 Wk High: $ 3.16
Volume (M$): $ 42 52 Wk Avg: $1.60
Open: $0.28 52 Wk Low: $0.25



 Market Capitalization (Millions $) 4
 Shares Outstanding (Millions) 12
 Employees 11
 Revenues (TTM) (Millions $) 9
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Bioaffinity Technologies Inc
Bioaffinity Technologies Inc. is a biotechnology company that focuses on the development and commercialization of innovative diagnostic tests. The company specializes in creating highly sensitive and specific tests for the early detection of various diseases, including cancer. Bioaffinity Technologies utilizes a proprietary technology called the Affinity Matrix, which allows for the detection of disease-specific biomarkers. This technology offers significant advantages over traditional diagnostic methods, such as improved accuracy and faster results. The company's goal is to improve patient outcomes by providing healthcare professionals with reliable and timely diagnostic tools.


   Company Address: 3300 Nacogdoches Road San Antonio 78217 TX
   Company Phone Number: 698-5334   Stock Exchange / Ticker: NASDAQ BIAF


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EXAS   -0.07%    
FLGT        1.07% 
FTRE   -5.62%    
GH        3.76% 
NTRA        2.46% 
VCYT        1.57% 
• View Complete Report
   



Stocks on the Move

Market Turmoil Hits BioAffinity Technologies Understanding the Recent Stock Sell-Off and Future Potential

Published Mon, Aug 5 2024 4:39 PM UTC

BioAffinity Technologies Inc (BIAF): Analyzing the Recent Sell-Off Amid Market ConcernsBioAffinity Technologies Inc (NASDAQ: BIAF) recently experienced a significant sell-off, leading to its shares now trading at $1.73. This is a stark contrast to its performance earlier in the year, where it had outperformed the market, supported by a series of favorable developments and a...
Bioaffinity Technologies Inc

Bioaffinity Technologies Inc. Achieves Remarkable 261180.239% Revenue Growth in Latest Fiscal Period2.

Bioaffinity Technologies Inc, a medical laboratory company, has shown promising financial results in the most recent fiscal period. The company recorded a significant revenue increase to $2.41 million, indicating a solid growth of revenue compared to the same period last year. However, despite the revenue growth, Bioaffinity Technologies Inc experienced an increased loss per share at $-0.20.
In comparison to its sector peers in the Medical Laboratories industry, Bioaffinity Technologies Inc has outperformed on the business front. The sector as a whole witnessed a 2.66% revenue advance during the same period, highlighting the company's superior performance. This achievement suggests that Bioaffinity Technologies Inc has implemented effective strategies in capturing market share and generating revenue.






Bioaffinity Technologies Inc's Segments
Diagnostic R D    0.07 % of total Revenue
Laboratory Services    99.93 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com